Source and scope
This summary is bounded to the recommendations, population and decisions covered by Hyperbilirubinemia in term and late preterm newborns. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CPS jaundice
Source-attributed clinical priorities
- Measure bilirubin and interpret it by postnatal age, gestation and neurotoxicity risk rather than visual inspection alone.
- Assess feeding, weight, hemolysis and conjugated bilirubin and provide lactation support while treatment is arranged.
- Use the current CPS phototherapy and escalation thresholds and arrange reliable rebound and outpatient follow-up.
- Visual assessment alone is unreliable; measure bilirubin and plot it against age in hours and gestation.
sources for this section:CPS jaundice
Practical assessment and management workflow
1
Record birth and maternal blood groups, gestation, bruising, feeding, weight, urine, stool and family history.
2
Measure total and direct bilirubin and evaluate hemolysis or illness when indicated.
3
Use the current CPS thresholds for phototherapy and escalation and support effective feeding.
4
Arrange repeat bilirubin and clinical follow-up after discharge or treatment according to rebound risk.
sources for this section:CPS jaundice
Safety, red flags and urgent escalation
- Jaundice in the first 24 hours requires urgent investigation.
- Lethargy, poor feeding, abnormal tone or a rapidly rising bilirubin needs emergency escalation.
- Conjugated hyperbilirubinemia is never physiologic and requires prompt cholestasis assessment.
sources for this section:CPS jaundice
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CPS jaundice
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CPS jaundice
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Paediatric SocietyHyperbilirubinemia in term and late preterm newbornsaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.